Loading news...
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Envista Holdings is upgraded from "Hold" to "Buy" ahead of its FY25 results, anticipating an earnings beat. Analyst forecasts appear overly conservative; NVST's cost optimization, share buybacks, and product traction suggest upside to consensus EPS. Recent investor events and sector surveys indicate strong momentum in implants, clear aligners, and diagnostic segments, with favorable market trends.
SG Americas Securities LLC lifted its position in Envista Holdings Corporation (NYSE: NVST) by 141.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 41,782 shares of the company's stock after purchasing an additional 24,446 shares during the quarter. SG Americas
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Envista Holdings Corporation (NVST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026.
BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will present at the 44th Annual J.P.
Envista's global expansion, bolt-on acquisitions, and strong balance sheet support growth, even as currency swings pressure sales.
Envista (NYSE: NVST - Get Free Report) and BioLife Solutions (NASDAQ: BLFS - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Risk and Volatility Envista has a beta of 0.99,
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Aaron Wealth Advisors LLC acquired a new position in shares of Envista Holdings Corporation (NYSE: NVST) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 28,411 shares of the company's stock, valued at approximately $579,000. Other hedge
Envista Holdings Corporation (NYSE: NVST - Get Free Report) has earned an average rating of "Hold" from the sixteen ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, five have issued a buy rating and one has issued
Frontier Capital Management Co. LLC lowered its stake in Envista Holdings Corporation (NYSE: NVST) by 2.3% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 1,204,476 shares of the company's stock after selling 28,245 shares during the period. Frontier Capital Management Co. LLC
Ariel Investments LLC boosted its position in Envista Holdings Corporation (NYSE: NVST) by 1.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,355,666 shares of the company's stock after purchasing an additional 210,921 shares during the period. Envista comprises 2.7%
Envista Holdings Corporation (NVST) Presents at Evercore 8th Annual Healthcare Conference Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BREA, Calif. , Nov. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the 8th Annual Evercore Healthcare Conference.
Teacher Retirement System of Texas decreased its position in shares of Envista Holdings Corporation (NYSE: NVST) by 14.7% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,396 shares of the company's stock after selling 13,042
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Envista Holdings Corporation ( NVST ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Jim Gustafson - Vice President of Investor Relations Paul Keel - CEO & Director Eric Hammes - Senior VP & CFO Conference Call Participants Allen Lutz - BofA Securities, Research Division Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Linda Bolduc - Morgan Stanley, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Michael Sarcone - Jefferies LLC, Research Division Russell Yuen - William Blair & Company L.L.C.